北大医药：子公司3000万元开展证券投资

Core Viewpoint - The company, Peking University Medicine (000788), announced that its wholly-owned subsidiary, New Advantage Health Industry Development Co., Ltd., will utilize its own funds to engage in securities investment activities [1] Summary by Categories Investment Details - The investment will be based on a registered capital of RMB 30 million, with the potential for reinvestment of the profits generated from the investments, excluding the initial investment amount of RMB 30 million [1] - The total investment amount for securities will not exceed 10% of the company's most recent audited net assets, allowing for the capital to be recycled within this limit [1] - The investment methods will include on-market stock and bond investments, explicitly excluding derivative trading [1] - The investment period is valid for 12 months from the date of approval by the board of directors [1]